Wegovy for weight management: Variable
Ozempic and Wegovy are once-weekly subcutaneous injections delivered in multi-dose pens
However, some patients may experience persistent fatigue, which warrants further clinical evaluation to exclude other contributing factors such as nutritional deficiencies (particularly iron, vitamin B12, or vitamin D), thyroid dysfunction, or inadequate protein intake
Wegovy is FDA-approved for weight loss for those with a body mass index (BMI) 30 or 27 with one or more weight-related comorbidities, such as heart disease or untreated high blood pressure
No noticeable trends were found in the biochemistry parameters, including amylase, lipase and calcitonin, in any of the treatment or race groups
Transmutation of Human Glutathione Transferase A2-2 with Peroxidase Activity into an Efficient Steroid Isomerase